Short Answer

A clinical researcher expects that a new therapeutic drug will decrease symptom severity and selects a one-tailed tt-test to analyze the data. Apply the concepts of critical values and directional outcomes to explain the risk the researcher takes if the drug actually increases symptom severity.

Question: A clinical researcher expects that a new therapeutic drug will decrease symptom severity and selects a one-tailed tt-test to analyze the data. Apply the concepts of critical values and directional outcomes to explain the risk the researcher takes if the drug actually increases symptom severity.

Sample answer: By applying a one-tailed test, the researcher gains a less extreme critical value, which helps detect the predicted symptom decrease. However, if the drug increases symptoms (the unexpected direction), the researcher faces the risk of having zero chance of rejecting the null hypothesis, whereas a two-tailed test would have been able to detect this harmful effect.

Key points:

  • The less extreme critical value of a one-tailed test only assists when the observed difference is in the predicted direction.
  • An increase in symptom severity represents a change in the unexpected direction.
  • In the unexpected direction, the one-tailed test provides zero chance of rejecting the null hypothesis, leaving the researcher unable to detect the adverse effect.

Rubric: The response must apply the concepts to show that choosing a one-tailed test for its less extreme critical value poses the risk of having zero chance of rejecting the null hypothesis if the result is opposite to the prediction (increased symptom severity), unlike a two-tailed test which can identify effects in both directions.

0

1

Updated 2026-05-26

Contributors are:

Who are from:

Tags

KPU

Research Methods in Psychology - 4th American Edition @ KPU

Related